# Preclinical research platform for uterine leiomyoma: construction optimization and selection of animal models

**Authors:** Dan Wu, Jian Luo, Liyi Lin, Tingting Gu, Zhehui You

PMC · DOI: 10.3389/fvets.2026.1772750 · Frontiers in Veterinary Science · 2026-02-23

## TL;DR

This paper reviews and compares different animal models used to study uterine leiomyomas, aiming to improve research on their causes and treatments.

## Contribution

The paper proposes a framework for selecting and optimizing animal models to better study uterine leiomyoma pathogenesis and therapies.

## Key findings

- Four types of animal models are commonly used for uterine leiomyoma research.
- Each model has specific advantages and limitations depending on the research goal.
- A framework is proposed to match models with specific research objectives.

## Abstract

Uterine leiomyomas (ULs) are increasingly becoming a disease affecting women’s health and are one of the most common tumors of the female reproductive system. The pathogenesis of ULs remains incompletely understood, and abnormal hormone levels as well as genetic factors are considered to be causative factors. To further investigate the pathogenesis of this disease, explore new treatment options, and validate new therapeutic drugs, reliable animal models are indispensable. The main animal models currently used for studying ULs include four categories: spontaneous animal models, genetically modified animal models, hormone-induced animal models, and xenograft animal models. This paper systematically reviews the advantages and disadvantages of these four major animal models, their applicable scenarios, proposes potential optimization strategies, and organizes a framework for matching research objectives with appropriate animal models, thereby promoting research on the mechanisms and treatment approaches of ULs.

## Linked entities

- **Diseases:** uterine leiomyoma (MONDO:0007886)

## Full-text entities

- **Genes:** Tsc2 (TSC complex subunit 2) [NCBI Gene 24855] {aka Rc}, MED12 (mediator complex subunit 12) [NCBI Gene 9968] {aka ARC240, CAGH45, FGS1, HDKR, HOPA, Kto}, AMHR2 (anti-Mullerian hormone receptor type 2) [NCBI Gene 269] {aka AMHR, MISR2, MISRII, MRII}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, TSC2 (TSC complex subunit 2) [NCBI Gene 7249] {aka LAM, PPP1R160, TSC4}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}
- **Diseases:** fibroid (MESH:D007889), uterine smooth muscle tumors (MESH:D018235), myometrial hyperplasia (MESH:D006965), pelvic pain (MESH:D017699), immunodeficient (MESH:D007153), abnormal uterine bleeding (MESH:D014592), infertility (MESH:D007246), Qi Stagnation and Blood Stasis (MESH:D014647), trauma (MESH:D014947), UL (OMIM:150699), renal and hepatic tumors (MESH:D009369)
- **Chemicals:** estradiol benzoate (MESH:C074283), diethylstilbestrol (MESH:D004054), vitamin D3 (MESH:D002762), progesterone (MESH:D011374), resveratrol (MESH:D000077185), epinephrine (MESH:D004837)
- **Species:** Coturnix japonica (Japanese quail, species) [taxon 93934], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** c.131G > A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967960/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967960/full.md

---
Source: https://tomesphere.com/paper/PMC12967960